Brief: China Pharma Holdings Inc reports third quarter results
15/11/2018 11:09
Nov 15 (Reuters) - China Pharma Holdings Inc CPHI.A :
* CHINA PHARMA HOLDINGS, INC. REPORTS THIRD QUARTER 2018
FINANCIAL
RESULTS
* Q3 LOSS PER SHARE $0.04
* Q3 REVENUE FELL 27.3 PERCENT TO $2.3 MILLION
* CHINA PHARMA HOLDINGS - AS OF SEPT 30 HAD CASH AND CASH
EQUIVALENTS OF $0.7 MILLION VERSUS $2.0 MILLION AS OF DEC 31,
2017
* CHINA PHARMA - ONGOING GENERIC DRUG CONSISTENCY
EVALUATIONS,
REFORM OF CHINA'S DRUG PRODUCTION POLICIES WILL SIGNIFICANTLY
IMPACT CHINESE DRUG MAKERS
Source text for Eikon: ID:nPnbWtwJJa
Further company coverage: CPHI.A
((Briefs@thomsonreuters.com;))
Recent news on China Pharma Holdings
See all newsBrief: China Pharma - Not Aware Of Any Material Corporate Developments Explaining Recent Market Activity
Brief: China Pharma Says Co Knows Of No Events That Could Have Caused Unusual Market Activity
Brief: China Pharma Holdings Inc - NYSE American Contacts China Pharma Regarding Unusual Market Activity On May 12 And 13
Brief: China Pharma Holdings Files For Non-Timely 10-K With US SEC
Brief: China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split